-- UroGen Pharma (URGN) has an average rating of buy and mean price target of $34.62, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $25.55, Change: $-0.70, Percent Change: -2.69%